A new report from the National Council of Applied Bioengineers (NCAB) estimates that more than 500 bioengineers, including some of the largest bioengineer companies in the world, are working on new bioengineering applications for medical purposes, including medical devices, diagnostics and other medical technologies.
Bioengineering is the science and technology that uses living cells to engineer the structure of living organisms.
NCAB’s report on Bioengineered Health was released Wednesday, and it offers the latest evidence on the use of bioengineerers in the medical industry.
The report says that of the 500 bioengineering companies working on bioengineering applications, more than 100 have made significant progress toward achieving their goals.
About 20 percent of the bioengineerer companies are making significant progress, and of the remaining bioenginerers, about a third are making progress toward their goals, the report says.
About a quarter of the companies are working toward a goal of using bioengineering for human-to-human communication, with a quarter making progress.
About a third of the efforts to date have been in the area of human-animal interactions.
The remaining Bioengineer firms are also working toward developing bioengine technologies that can be used for human use.
The report says bioengineation is a key area for the bioengineering industries and that the bioelectronic technologies are being used to develop new technologies to improve healthcare.
“Bioengineering is an area where we can leverage our technological advantage in order to make the world a better place,” said Kevin Buehler, chief executive officer of NCAB.
“It is a technology that will benefit society in a way that we never thought possible.
Bioengineering is the future of medicine and the future for bioengineering is here.”NCAB estimates that the United States is home to more than 1,400 bioengineerdas.
More than 20 percent have achieved significant progress on their goals and nearly all of those companies are also making significant strides, NCAB found.
The bioengineering firms in the United Kingdom are also a notable presence.
The UK is home of BioEngineered Healthcare, a biotechnology firm that is the leader in the development of bioelectronics and bioprinting technology.